Geron
GERN
#6280
Rank
โ‚น75.12 B
Marketcap
โ‚น117.69
Share price
3.15%
Change (1 day)
-65.08%
Change (1 year)

Geron (GERN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น28.62 Billion

According to Geron's latest financial reports the company's total liabilities are โ‚น28.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Geron - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น26.89 B121.05%
2023-12-31โ‚น12.16 B32.95%
2022-12-31โ‚น9.15 B23.41%
2021-12-31โ‚น7.41 B69.59%
2020-12-31โ‚น4.37 B101.93%
2019-12-31โ‚น2.16 B310.08%
2018-12-31โ‚น0.52 B26.9%
2017-12-31โ‚น0.41 B-22.19%
2016-12-31โ‚น0.53 B21.29%
2015-12-31โ‚น0.44 B-83.36%
2014-12-31โ‚น2.64 B465.18%
2013-12-31โ‚น0.46 B-39.49%
2012-12-31โ‚น0.77 B8.92%
2011-12-31โ‚น0.71 B-61.15%
2010-12-31โ‚น1.83 B405.44%
2009-12-31โ‚น0.36 B-2.94%
2008-12-31โ‚น0.37 B-28.09%
2007-12-31โ‚น0.51 B-75.01%
2006-12-31โ‚น2.07 B80.63%
2005-12-31โ‚น1.14 B170.57%
2004-12-31โ‚น0.42 B-20.86%
2003-12-31โ‚น0.53 B-63.8%
2002-12-31โ‚น1.48 B-11.39%
2001-12-31โ‚น1.67 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
โ‚น0.23 B-99.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น3.330 T 11,534.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น50.33 B 75.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚น150.84 B 426.92%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚น12.36 B-56.82%๐Ÿ‡บ๐Ÿ‡ธ USA